APA (7th ed.) Citation

DM, B., CC, W., D, B., JS, H., WL, C., A, E., . . . R, V. (2021). Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial. JAMA ophthalmology, 139(9), 946. https://doi.org/10.1001/jamaophthalmol.2021.2809

Chicago Style (17th ed.) Citation

DM, Brown, et al. "Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial." JAMA Ophthalmology 139, no. 9 (2021): 946. https://doi.org/10.1001/jamaophthalmol.2021.2809.

MLA (9th ed.) Citation

DM, Brown, et al. "Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial." JAMA Ophthalmology, vol. 139, no. 9, 2021, p. 946, https://doi.org/10.1001/jamaophthalmol.2021.2809.